NCT01244217 - Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Perennial Allergic Rhinitis (PAR) | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

July 31, 2011

Study Completion Date

August 31, 2011

Conditions

Rhinitis Perennial

Interventions

DRUG

fexofenadine/Allegra (M016455)

"Pharmaceutical form:dry syrup formulation to be suspended in water~Route of administration: oral"

Trial Locations (15)

Sanofi-Aventis Investigational Site Number 392015, Fukuoka

Sanofi-Aventis Investigational Site Number 392012, Kanazawa

Sanofi-Aventis Investigational Site Number 392001, Kawaguchi-Shi

Sanofi-Aventis Investigational Site Number 392003, Kawasaki-Shi

Sanofi-Aventis Investigational Site Number 392004, Kawasaki-Shi

Sanofi-Aventis Investigational Site Number 392002, Kita-ku

Sanofi-Aventis Investigational Site Number 392011, Kofu

Sanofi-Aventis Investigational Site Number 392014, Obu-Shi

Sanofi-Aventis Investigational Site Number 392013, Seki-Shi

Sanofi-Aventis Investigational Site Number 392005, Yokohama

Sanofi-Aventis Investigational Site Number 392006, Yokohama

Sanofi-Aventis Investigational Site Number 392007, Yokohama

Sanofi-Aventis Investigational Site Number 392008, Yokohama

Sanofi-Aventis Investigational Site Number 392009, Yokohama

Sanofi-Aventis Investigational Site Number 392010, Yokohama